A systematic review and meta-analysis on the risk factors of acute myeloid leukemia

被引:12
|
作者
Guo, Yanrong [1 ]
Wang, Wenwen [1 ]
Sun, Huali [2 ]
机构
[1] Taizhou Cent Hosp, Dept Hematol, Taizhou Univ Hosp, Taizhou, Peoples R China
[2] Taizhou Cent Hosp, Radiotherapy Sect, Taizhou Univ Hosp, 999,Donghai Ave, Taizhou, Peoples R China
关键词
Acute myeloid leukemia (AML); family tumor history; hepatitis B virus infection rate (HBV infection rate); hepatitis C virus infection rate (HCV infection rate); environmental exposure rate; CHILDHOOD ACUTE-LEUKEMIA; FAMILY-HISTORY; HEPATITIS-B; CANCER; EXPOSURE; CHILDREN;
D O I
10.21037/tcr-22-27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Acute myeloid leukemia (AML) is one of the main types of leukemia that threatens the life and health of patients. A large number of clinical studies have been conducted on the etiology of the disease. However, there are few evidence-based medical studies and no definitive treatment guidelines. Methods: Related articles were searched from Medline, Excerpta Medica Database (EMBASE), EBSCO, OVID, Chinese Biology Medicine Disc (CBMDISC), and Wanfang databases. The search time limit was from the establishment of the database to September 2021. The search terms were as follows: acute myeloid leukemia, AML, electromagnetic field, case-control study, cohort study, and risk factors. All literatures were included according to PICOS standards, and the risk of deviation and literature quality were assessed. RevMan 5.3 software was used for meta-analysis. Results: The 10 articles included were of high quality and low bias risk. The research results showed that compared with healthy people, among the risk factors for AML, family tumor history [risk ratio (RR) =0.98; 95% confidence interval (CI): (0.57, 1.69); Z=0.08; P=0.94] and the hepatitis B virus (HBV) infection rate [odds ratio (OR) =1.34; 95% CI: (0.57, 3.13); Z=0.68; P=0.50] showed no significant differences, but the hepatitis C virus (HCV) infection rate [OR =1.60; 95% CI: (1.17, 2.19); Z=2.92; P=0.003] and environmental exposure rate [OR =1.49; 95% CI: (1.01, 2.21); Z=2.02; P=0.04] increased significantly. Conclusions: A total of 10 articles were included to analyze AML risk factors and related content. The results suggested that HCV infection and environmental exposure history such as home decoration were risk factors for AML.
引用
收藏
页码:796 / 804
页数:9
相关论文
共 50 条
  • [1] Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis
    Horowitz, Netanel A.
    Henig, Israel
    Henig, Oryan
    Benyamini, Noam
    Vidal, Liat
    Avivi, Irit
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 610 - 616
  • [2] Venetoclax and azacitidine for acute myeloid leukemia patients: a systematic review and meta-analysis
    Noersamsjah, A. M.
    Lim, Y.
    Chandra, A. I.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1368 - S1368
  • [3] Early Life Nutrition Factors and Risk of Acute Leukemia in Children: Systematic Review and Meta-Analysis
    Kintossou, Ambroise Kouame
    Blanco-Lopez, Jessica
    Iguacel, Isabel
    Pisanu, Silvia
    Almeida, Claudia Choma Bettega
    Steliarova-Foucher, Eva
    Sierens, Ciska
    Gunter, Marc J.
    Ladas, Elena J.
    Barr, Ronald D.
    Van Herck, Koen
    Kozlakidis, Zisis
    Huybrechts, Inge
    NUTRIENTS, 2023, 15 (17)
  • [4] Efficacy and safety of lenalidomide for the treatment of acute myeloid leukemia: a systematic review and meta-analysis
    Xie, Chun-Hong
    Wei, Min
    Yang, Fei-Yan
    Wu, Fu-Zhen
    Chen, Lei
    Wang, Jian-Kun
    Liu, Qin
    Huang, Jin-Xiong
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3637 - 3648
  • [5] Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis
    Al-Bulushi, Fatma
    Al-Riyami, Rahma
    Al-Housni, Zainab
    Al-Abri, Bushra
    Al-Khabori, Murtadha
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis
    Shimony, Shai
    Rozental, Alon
    Bewersdorf, Jan P.
    Goldberg, Aaron D.
    Stein, Eytan M.
    Grimshaw, Alyssa A.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Wolach, Ofir
    Stahl, Maximilian
    HAEMATOLOGICA, 2022, 107 (12) : 2955 - 2960
  • [7] Comparison of Azacitidine and Decitabine for the Treatment of Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Saiz-Rodriguez, Miriam
    Cuevas, Beatriz
    Martinez-Cuadron, David
    Campuzano, Veronica
    Cuevas, Maria Victoria
    Hermida, Gerardo
    Alvarez, Rodolfo
    Gonzalez-Lopez, Tomas Jose
    Diaz-Galvez, Francisco Javier
    Alcaraz, Raquel
    de Vicente, Pilar
    Sanz, Miguel A.
    Montesinos, Pau
    Labrador, Jorge
    BLOOD, 2020, 136
  • [8] Impact of Mutations in Epigenetic Modifiers in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Bulushi, Fatma
    Al-Riyami, Rahma
    Al Hosni, Zainab
    Al-Abri, Bushra
    Al-Khabori, Murtadha
    BLOOD, 2019, 134
  • [9] Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis
    Bewersdorf, Jan P.
    Giri, Smith
    Tallman, Martin S.
    Zeidan, Amer M.
    Stahl, Maximilian
    TRANSFUSION, 2020, 60 (10) : 2360 - 2369
  • [10] Birth Weight and Subsequent Risk of Total Leukemia and Acute Leukemia: A Systematic Review and Meta-Analysis
    Che, Hailuo
    Long, Dunmei
    Sun, Qian
    Wang, Lina
    Li, Yunbin
    FRONTIERS IN PEDIATRICS, 2021, 9